FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of Emicizumab
Authors:
Johannes Oldenburg1*; Gary Benson2; Pratima Chowdary3; Robert Klamroth4,5; Anne Lienhart6; Davide Matino7; Camila Martins Mazini Tavares8 Keiji Nogami9 Flora Peyvandi10,11; Amalie Rhode Høgh Nielsen8; Guy Young12; Allison P Wheeler13
Affiliations
View DetailsHide Details
{{ getPageNum(PDFPage) }}
Share
Copy link
{{pageUrl}}
Keywords
Rare Blood Disorders
Congress oral presentation
Mim8
Get notified when materials for ISTH 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
Get notified when materials for ISTH 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
{{ error.$message }}
Success
We will notify you when new materials become available for ISTH 2025 and future congresses.
We will keep you updated in your inbox:
Subscribe to receive updates on related congresses in the same disease area: